Search results
Results from the WOW.Com Content Network
490 Bronchitis, not specified as acute or chronic; 491 Chronic bronchitis; 492 Emphysema. 492.0 Emphysematous bleb; 492.8 Other emphysema; 493 Asthma. 493.0 Extrinsic asthma; 493.1 Intrinsic asthma; 493.2 Chronic obstructive asthma; 494 Bronchiectasis; 495 Extrinsic allergic alveolitis; 496 Chronic airway obstruction, not elsewhere classified ...
Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes , some having protective effect, with each gene having its own tendency to be influenced by the environment although a ...
Chronic obstructive pulmonary disease: COVID-19 Coronavirus disease 2019: CP Cerebral palsy: CP/CPPS: Chronic prostatitis/chronic pelvic pain syndrome: CPDD Calcium pyrophosphate deposition disease: CPM Central pontine myelinolysis: CPPS Chronic pelvic pain syndrome (see UCPPS) CRE Carbapenem-resistant Enterobacteriaceae: CRF Chronic renal ...
Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...
Bronchial hyperresponsiveness is a hallmark of asthma but also occurs frequently in people with chronic obstructive pulmonary disease (COPD). [2] In the Lung Health Study, bronchial hyperresponsiveness was present in approximately two-thirds of patients with non-severe COPD, and this predicted lung function decline independently of other ...
Asthma, particularly severe asthma, is strongly associated with development of chronic obstructive pulmonary disease (COPD). [31] [32] [33] Those with asthma, especially if it is poorly controlled, are at increased risk for radiocontrast reactions. [34] Cavities occur more often in people with asthma. [35]
While the acronyms are similar, reactive airway disease (RAD) and reactive airways dysfunction syndrome (RADS) are not the same. [1]Reactive airways dysfunction syndrome was first identified by Stuart M. Brooks and colleagues in 1985 as an asthma-like syndrome developing after a single exposure to high levels of an irritating vapor, fume, or smoke.
AERD affects an estimated 0.3–0.9% of the general population in the US, including around 7% of all asthmatics, about 14% of adults with severe asthma, and ~5-10% of patients with adult onset asthma. [2] [3] [8] AERD is uncommon among children, with around 6% of patients, predominantly female, reporting disease onset during childhood. [9]